Abstract:Background: Hyperhomocysteinemia (HHcy) is related to liver diseases, such as nonalcoholic fatty liver (NAFL). Although the precise pathogenesis of NAFL is still largely unknown, the links between organs seem to play a vital role. The current study aimed to explore the role of white adipose tissue in homocysteine (Hcy)-induced NAFL. Methods: Blood samples from nonhyperhomocysteinemia or hyper-homocysteinemia individuals were collected to assess correlation between Hcy and TG or FFAs levels. C57BL/6 mice were maintained on a high-methionine diet or administered with Hcy (1.8 g/l) in the drinking water to establish an HHcy mouse model. Lipolytic response was measured in adipose tissue or 3T3L-1 cells. Hif1a∆adipo mice and lentivirus construction were employed for mechanistic studies. Findings: We demonstrated that Hcy activated adipocyte lipolysis and that this change was accompanied by an increased release of fatty acids (FAs) and glycerol. Excessive FAs were taken up by hepatocyte, which resulted in lipid accumulation in the liver. Treatment with acipimox (0.08 g kg −1 day−1), a potent chemical inhibitor of lipolysis, markedly decreased the Hcy-induced NAFL. Mechanistically, hypoxia-inducible factor 1α (HIF1α)-endoplasmic reticulum oxidoreductin 1α (ERO1α) mediated pathway promoted ROS accumulation and induced ER overoxidation, ER stress and more closed ER-lipid droplet interactions, which were responsible for activating the lipolysis response. Specific disruption of adipocyte HIF1α reversed Hcy-induced lipolysis and alleviated the excess hepatic TG content. Interpretation: This study reveals that Hcy activates lipolysis via adipocyte HIF1α-ERO1α-mediated pathway and suggests the potential utility of targeted adipocyte HIF1α inhibition for treating Hcy-induced NAFL. Funding Statement: This work was supported by the National Natural Science Foundation of the People’s Republic of China (No. 31872787, 91739303, 91857115, 31925021, and 31771261) and the Youth Innovation Promotion Association, CAS (to LW). Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: Plasma was obtained from 38 individuals with hyperhomocysteinemia and 52 nonhyperhomocysteinemia from Peking University Third Hospital and was approved by the Ethics Committee of Peking University Third Hospital. Informed consent prior to participation was provided by all subjects. All animal studies were performed in compliance with the guidelines of the Institute of Laboratory Animal Resources and were approved by the Animal Care and Use Committee of Peking University.

Hepatocyte Proliferation During Liver Regeneration is Impaired in Mice with Methionine Diet-Induced Hyperhomocysteinemia.

Homocysteine enhances cell proliferation in hepatic myofibroblastic stellate cells

Activation and Proliferation of Hepatic Stellate Cells Induced by Homocysteine in Hepatic Fibrosis

Reduced Number and Activity of Circulating Endothelial Progenitor Cells from Patients with Hyperhomocysteinemia.

Effect of Homocysteine -Mediated Endoplasmic Reticulum Stress on Lipid Metabolism in Hepatocytes

Abstract 4137257: Hepatocyte Growth Factor -Mediated Angiogenesis Supersession in Hyperhomocysteinemia

Hcy promotes the formation of atherosclerotic and effect of liver lipid metabolism disorder in ApoE-/- mice

Homocysteine downregulates gene expression of heme oxygenase-1 in hepatocytes

Effect of homocysteine on proliferation and expression of CyclinD 1,ALT and AST in hepatic cells

Homocysteine Promotes Hepatic Steatosis by Activating the Adipocyte HIF1α-ERO1α-Lipolysis Pathway

Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor/cd36 Pathway to Promote Hepatic Steatosis in Mice

Hyperhomocysteinemia Activates Aryl Hydrocarbon Receptor-Cd36 Pathway to Promote Hepatic Steatosis in Mice Liver

Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1α-ERO1α-dependent oxidative stress manner

Homocysteine Impaired Endothelial Function Through Compromised Vascular Endothelial Growth Factor/Akt/Endothelial Nitric Oxide Synthase Signalling

Hyperhomocysteinemia Results From And Promotes Hepatocellular Carcinoma Via Cyp450 Metabolism By Cyp2j2 Dna Methylation

Altered gene expression in liver from a murine model of hyperhomocysteinemia

Homocysteine impaired endothelial function via compromised VEGF/Akt/eNOS signaling (Revised 1)

Role of SREBP-1C and GRP-94 in Hepatocytes Lipids Metabolism of Mice

Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats

Homocysteine promotes cardiac fibrosis by regulating the Akt/FoxO3 pathway

Homocysteine Inhibits Endothelial Progenitor Cells Proliferation Via DNMT1-mediated Hypomethylation of Cyclin A.